Brighter AB is a Swedish company that develops medical devices to treat diseases with a high unmet need. Its lead product in development is Actiste, for diabetes management.
The diabetes market is large and growing, and many patients do not adhere adequately to therapy. Brighter's solution, Actiste, offers a unique and easy solution to this problem, which should enable it to capture significant market share.
The company is not yet profitable, and has no products on the market at present. Nor is there any guarantee that it will be able to bring any products to the market in future. The company will need to raise additional capital to fund future operations.